A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...

Researchers evaluated the real-world effectiveness of nirsevimab in preventing ICU admission and acute respiratory failure associated with RSV among infants.

The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.

GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory ...

Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered compelling evidence that early-infancy infection with respiratory syncytial virus (RSV) ...

After a Type C discussion, Blue Lake got the FDA nod to enrol both RSV-positive and negative children above the age of 18 months in the study. This leaves the US-based biotech open to potentially ...

The season of never-ending sneezing and stuffy noses is underway, sending Americans to pharmacy lines in hopes of keeping illness at bay with yearly shots. While flu and COVID-19 vaccines are an ...